Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for argatroban (compound)
Most Correlated Studies
- Drug target sets for approved compounds
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
Most Relevant Literature
- A Case of Argatroban Refractory Heparin Induced Thrombocytopenia and Thrombosis.
- Argatroban in Patients With Acute Ischemic Stroke With Early Neurological Deterioration: A Randomize…
- Argatroban Use in Pediatric Patients Supported by Paracorporeal Ventricular Assist Devices.
- Membrane oxygenator longevity was higher in argatroban-treated patients undergoing vvECMO.
- Intraoperative argatroban vessel irrigation during microsurgical anastomosis in heparin-induced thro…
Most Relevant Clinical Trials
- Safety of Argatroban Infusion in Conduction Disturbances
- Argatroban Stroke Treatment - A Pilot Safety Study
- Safety and Feasibility of Argatroban, Tissue Plasminogen Activator and Intra-arterial Therapy in Str…
- Argatroban Versus Lepirudin in Critically Ill Patients
- Safety and Efficacy of Argatroban Applicated in Anticoagulation of V-V ECMO
